Natural killer T cells in advanced melanoma patients treated with tremelimumab - Wikidata - wikimedia - TriplyDB

Natural killer T cells in advanced melanoma patients treated with tremelimumab

Natural killer T cells in advanced melanoma patients treated with tremelimumab

http://www.wikidata.org/entity/Q35027661

about

Tremelimumab: research and clinical development HIV-1 Infection Accelerates Age According to the Epigenetic Clock.PD-1 Blockade Expands Intratumoral Memory T Cells.Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients.Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review.Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single-centre analysis.A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication.Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.

P2860

Q26752822-A796BA59-0125-46AF-9686-1446EDFBDF78 Q34476144-F5CF6AB5-937C-4AD3-A1A9-2EF643F951EF Q36642804-9A284E0D-DDC6-49FA-8A6E-1817064D4625 Q38603237-E53A1C62-E125-4D18-A333-D82CCE2DD9DD Q38890435-73424C65-E1BF-4A71-8CD5-5BB3BC6A073A Q42369277-A5346ADD-37BA-4E9B-9845-570154996389 Q47812209-8E7911A0-9B82-46A2-B000-FAC54CF9CDEC Q48184244-6B13A685-A143-4572-9585-250989414675 Q50535275-1474A420-A23A-4CB6-B716-F4FEB17D9461

P2860

Natural killer T cells in advanced melanoma patients treated with tremelimumab

http://www.wikidata.org/entity/Q35027661

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Natural killer T cells in advanced melanoma patients treated with tremelimumab

@ast

Natural killer T cells in advanced melanoma patients treated with tremelimumab

@en

type

label

Natural killer T cells in advanced melanoma patients treated with tremelimumab

@ast

Natural killer T cells in advanced melanoma patients treated with tremelimumab

@en

prefLabel

Natural killer T cells in advanced melanoma patients treated with tremelimumab

@ast

Natural killer T cells in advanced melanoma patients treated with tremelimumab

@en

P1433

Q35027661-1BDE5221-750A-4D1D-948E-D9DE832CC27F

P1476

Q35027661-DB3C519E-7F35-47BB-B1DB-616B556625FA

P2093

Q35027661-07B009C8-6DF0-4C05-B983-E0CBB2A2281A

Q35027661-55CC8C50-415A-4E37-AD16-0D0B1852D8BF

Q35027661-6A8FCB44-8FE4-4A74-9774-1C2E8638526F

Q35027661-74921FFE-BC02-45D8-B39D-8E85C8129948

Q35027661-BE4ED9F4-544A-484D-821C-3EFDB49246BA

Q35027661-C5A06D3F-63AB-46F0-BCE8-B0E815F28882

Q35027661-CA3CF167-D243-4DEA-8350-FBA65135F639

Q35027661-D3A1F4E5-5B9B-4A5D-B271-8D538CEB1A3D

Q35027661-E2766A9D-5A8B-4C6D-B766-2CCE1F212CBA

Q35027661-EEA28B40-0449-4846-B3EF-32694B7FC159

P2860

Q35027661-02059200-2E0C-4B8C-96B3-5AE0EC78D07F

Q35027661-05675C96-189C-4023-8DCD-418E3E2302C2

Q35027661-0E52B3BA-BA6F-4065-9DDB-B8DFEE7CC128

Q35027661-0FAB40DC-2631-47CD-812E-A2FB5E1C950C

Q35027661-179366EA-5744-4FF3-B887-11B4531E68C2

Q35027661-2AFE144A-12C8-4567-B7E6-F3BBBE51EC93

Q35027661-413021F5-4993-4D15-BBD2-2B387C897EE4

Q35027661-4304B47C-4707-4663-A87D-2F9AC9E3F84B

Q35027661-4572C078-9510-4B04-813D-811753864C21

Q35027661-578D8646-2741-4B66-A131-F78A7AC5826C

P304

Q35027661-247F495C-72FA-4829-A190-5A048DE8CAD5

P31

Q35027661-03C084E9-8423-4CF3-9539-247F5CB4E5E3

P356

Q35027661-F441E09A-A367-45DE-A8D2-27C0BFA82EFF

P407

Q35027661-1A7B1373-88BA-439D-BF7A-0F73DE75AF6A

P433

Q35027661-8E783B0F-4636-473D-BF7D-A9E84C11FEBF

P478

Q35027661-00C24327-0666-449D-8F62-BC98C9ACD11B

P50

Q35027661-17F29942-8A52-4673-AF02-DE7127B9D84D

Q35027661-41165F26-10EE-4C6F-9020-FBBA5703B4A5

Q35027661-889807A2-AF59-44FD-8987-7F7BBFE5EEEE

P577

Q35027661-E21032CC-21AB-49F5-8F32-6E517907B4B3

P5875

Q35027661-B095937B-714D-4FEA-97B7-8B8D79C7D6F2

P698

Q35027661-861C8A37-0915-4E6A-A1F8-4CD20B9AEFC1

P932

Q35027661-DF87E5C7-8463-4365-B17E-4F376DC16B26

P356

JOURNAL.PONE.0076829

P1433

P1476

Natural killer T cells in advanced melanoma patients treated with tremelimumab

@en

P2093

Beth D Jamieson

http://www.w3.org/2001/XMLSchema#string

Earl Avramis

http://www.w3.org/2001/XMLSchema#string

F Javier Ibarrondo

http://www.w3.org/2001/XMLSchema#string

Hooman Sazegar

http://www.w3.org/2001/XMLSchema#string

Ingrid Schmid

http://www.w3.org/2001/XMLSchema#string

Jason Jalil

http://www.w3.org/2001/XMLSchema#string

Jesus Gomez-Navarro

http://www.w3.org/2001/XMLSchema#string

Otto O Yang

http://www.w3.org/2001/XMLSchema#string

Richard C Koya

http://www.w3.org/2001/XMLSchema#string

Thinle Chodon

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

The role of NKT cells in tumor immunity

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

New ways to turn on NKT cells

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Human NKT cells express granulysin and exhibit antimycobacterial activity

P304

e76829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0076829

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Bartosz Chmielowski

Begoña Comin-Anduix

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258117702

http://www.w3.org/2001/XMLSchema#string

P698

24167550

http://www.w3.org/2001/XMLSchema#string

P932

3805549

http://www.w3.org/2001/XMLSchema#string